Showing results (561-570 of 657) with videos related to
Sort By:
Pageof 66
British Journal of Cancer|September 6, 2021
Trajectories of alcohol consumption during life and the risk of developing breast cancerCarolina Donat-Vargas, Ángel Guerrero-Zotano, Ana Casas, et al.Clinical and Experimental Rheumatology|November 28, 2022
Safety and efficacy of SARS-CoV-2 vaccination in 1237 patients with primary Sjögren syndromeNevsun Inanc, Belchin Kostov, Roberta Priori, et al.Annals of the Rheumatic Diseases|February 6, 2021
EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19Alessia Alunno, Aurélie Najm, Pedro M Machado, et al.Journal of Hematology & Oncology|April 19, 2017
Characterization and risk estimate of cancer in patients with primary Sjögren syndromePilar Brito-Zerón, Belchin Kostov, Guadalupe Fraile, et al.European Journal of Cancer (Oxford, England : 1990)|April 16, 2022
Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL studyMiguel Martín, Christoph Zielinski, Manuel Ruiz-Borrego, et al.AIDS and Behavior|March 9, 2026
Community-Based Screening for HIV and Viral Hepatitis Using Dried Blood Spots in a Migrant Population in Spain: The HEPINMIGRA StudyJara Llenas-García, Miriam Navarro, Maria Paz Ventero, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 13, 2022
Critical role of acute hypoxemia on the cognitive impairment after severe COVID-19 pneumonia: a multivariate causality model analysisMiguel García-Grimshaw, Amanda Chirino-Pérez, Fernando Daniel Flores-Silva, et al.Annals of the Rheumatic Diseases|October 8, 2021
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19Alessia Alunno, Aurélie Najm, Pedro M Machado, et al.Scientific Reports|May 10, 2020
Primary breast cancer and health related quality of life in Spanish women: The EpiGEICAM case-control studyNerea Fernández de Larrea-Baz, Beatriz Pérez-Gómez, Ángel Guerrero-Zotano, et al.Clinical and Experimental Rheumatology|August 30, 2018
Severe, life-threatening phenotype of primary Sjögren's syndrome: clinical characterisation and outcomes in 1580 patients (GEAS-SS Registry)Alejandra Flores-Chávez, Belchin Kostov, Roser Solans, et al.Pageof 66